ginsenoside rh2 has been researched along with ciprofloxacin in 2 studies
Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (ciprofloxacin) | Trials (ciprofloxacin) | Recent Studies (post-2010) (ciprofloxacin) |
---|---|---|---|---|---|
295 | 1 | 200 | 16,060 | 1,331 | 6,092 |
Protein | Taxonomy | ginsenoside rh2 (IC50) | ciprofloxacin (IC50) |
---|---|---|---|
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | 0.41 | |
DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.31 | |
DNA gyrase subunit B | Staphylococcus aureus | 4.32 | |
DNA gyrase subunit A | Escherichia coli K-12 | 0.6845 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.5632 | |
DNA topoisomerase 4 subunit B | Staphylococcus aureus | 6.485 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 4.8011 | |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.41 | |
DNA gyrase subunit A | Staphylococcus aureus | 4.32 | |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.41 | |
DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
GABA theta subunit | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | 0.41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; He, J; Liu, J; Lu, M; Sun, X; Sun, Y; Wang, G; Wang, Y; Zhang, J; Zhang, X; Zhou, F | 1 |
Long, J; Lu, C; Pan, X; Sun, M; Wu, C; Zhu, C | 1 |
2 other study(ies) available for ginsenoside rh2 and ciprofloxacin
Article | Year |
---|---|
Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Ginsenosides; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Peritonitis; Protein Conformation; Pyronine; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus | 2014 |
PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ginsenosides; HaCaT Cells; Humans; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcal Skin Infections; Staphylococcus aureus | 2020 |